U.S. Markets closed

Yield10 Bioscience, Inc. (YTEN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
8.98+0.18 (+2.05%)
At close: 4:00PM EDT
9.15 +0.17 (1.89%)
After hours: 04:16PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close8.80
Open8.14
Bid8.82 x 1300
Ask9.20 x 800
Day's Range8.66 - 9.11
52 Week Range4.16 - 23.49
Volume37,799
Avg. Volume65,269
Market Cap43.69M
Beta (5Y Monthly)1.22
PE Ratio (TTM)N/A
EPS (TTM)-4.30
Earnings DateMar 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est25.33
  • Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances Using Camelina Platform to Produce PHA Bioplastic at 2021 Synthetic Biology: Engineering, Evolution and Design Virtual Conference
    GlobeNewswire

    Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances Using Camelina Platform to Produce PHA Bioplastic at 2021 Synthetic Biology: Engineering, Evolution and Design Virtual Conference

    WOBURN, Mass., June 16, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the 2021 Synthetic Biology: Engineering, Evolution & Design (SEED) conference, taking place in a virtual format June 15 through June 18, 2021. Dr. Snell will present at the conference on Wednesday, June 16 at 10:55 am PDT (1:55 pm EDT) during Session 4: Synthetic Biology for Agriculture, Fo

  • Yield10 Bioscience to Present at the LD Virtual Invitational XI on June 9, 2021
    GlobeNewswire

    Yield10 Bioscience to Present at the LD Virtual Invitational XI on June 9, 2021

    WOBURN, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will give a corporate presentation at the LD Micro Virtual Invitational XI investor conference on Wednesday, June 9, 2021 at 3:30 pm ET, Track Two. The virtual conference and presentation will be held via webcast from June 8 to 10, 2021. Register to watch the presentation here. Investors interested in scheduling a meeting with management should contact assistant@ldmicro.com. About Yield10 Bioscience Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the “Trait Factory”, to develop improved Camelina varieties for the production of proprietary seed products, and to discover high value genetic traits for the agriculture and food industries. Our goals are to efficiently establish a high value seed products business based on developing superior varieties of Camelina to produce feedstock oils, nutritional oils, and PHA bioplastics, and to license our yield traits to major seed companies for commercialization in major row crops, including corn, soybean and canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada. For more information about the company, please visit www.yield10bio.com, or follow the Company on Twitter, Facebook and LinkedIn. (YTEN-G) Contacts: Yield10 Bioscience:Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com Investor Relations: Bret Shapiro, (561) 479-8566, brets@coreir.comManaging Director, CORE IR Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank PR

  • Is Yield10 Bioscience (NASDAQ:YTEN) In A Good Position To Deliver On Growth Plans?
    CoinDesk

    Is Yield10 Bioscience (NASDAQ:YTEN) In A Good Position To Deliver On Growth Plans?

    Just because a business does not make any money, does not mean that the stock will go down. For example, although...